Table: Daito -Q1 group results

Daito Pharmaceutical

11/10/2024 07:01

Oct 11 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2024        Aug 31, 2023     May 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             12.68               12.18            49.00    
                 (+4.1 pct)          (+1.1 pct)       (+4.5 pct)  
  Operating        849 mln               1.08             3.50    
                 (-21.4 pct)         (-28.0 pct)      (-10.1 pct) 
  Recurring        983 mln               1.09             3.50    
                 (-10.0 pct)         (-26.0 pct)      (-10.8 pct) 
  Net              618 mln             683 mln            2.30    
                 (-9.6 pct)          (-27.7 pct)      (-30.2 pct) 
  EPS             40.42 yen           43.27 yen       150.39 yen  
  Ann Div                             60.00 yen        70.00 yen  
  -Q2 div                             30.00 yen        35.00 yen  
  -Q4 div                             30.00 yen        35.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T